| Literature DB >> 23932792 |
Jason T Manka1, Alice L Rodriguez, Ryan D Morrison, Daryl F Venable, Hyekyung P Cho, Anna L Blobaum, J Scott Daniels, Colleen M Niswender, P Jeffrey Conn, Craig W Lindsley, Kyle A Emmitte.
Abstract
Development of SAR in an octahydropyrrolo[3,4-c]pyrrole series of negative allosteric modulators of mGlu1 using a functional cell-based assay is described in this Letter. The octahydropyrrolo[3,4-c]pyrrole scaffold was chosen as an isosteric replacement for the piperazine ring found in the initial hit compound. Characterization of selected compounds in protein binding assays was used to identify the most promising analogs, which were then profiled in P450 inhibition assays in order to further assess the potential for drug-likeness within this series of compounds.Entities:
Keywords: Allosteric modulator; CNS; GPCR; Glutamate; Octahydropyrrolo[3,4-c]pyrrole; mGlu(1)
Mesh:
Substances:
Year: 2013 PMID: 23932792 PMCID: PMC3901432 DOI: 10.1016/j.bmcl.2013.07.029
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823